| Literature DB >> 34766906 |
Anastassios Karagiannis1, Thierry Gallopin2, Alexandre Lacroix1, Fabrice Plaisier1, Juliette Piquet1, Hélène Geoffroy2, Régine Hepp1, Jérémie Naudé1, Benjamin Le Gac1, Richard Egger3, Bertrand Lambolez1, Dongdong Li1, Jean Rossier1,2, Jochen F Staiger4, Hiromi Imamura5, Susumu Seino6, Jochen Roeper3, Bruno Cauli1.
Abstract
Glucose is the mandatory fuel for the brain, yet the relative contribution of glucose and lactate for neuronal energy metabolism is unclear. We found that increased lactate, but not glucose concentration, enhances the spiking activity of neurons of the cerebral cortex. Enhanced spiking was dependent on ATP-sensitive potassium (KATP) channels formed with KCNJ11 and ABCC8 subunits, which we show are functionally expressed in most neocortical neuronal types. We also demonstrate the ability of cortical neurons to take-up and metabolize lactate. We further reveal that ATP is produced by cortical neurons largely via oxidative phosphorylation and only modestly by glycolysis. Our data demonstrate that in active neurons, lactate is preferred to glucose as an energy substrate, and that lactate metabolism shapes neuronal activity in the neocortex through KATP channels. Our results highlight the importance of metabolic crosstalk between neurons and astrocytes for brain function.Entities:
Keywords: brain metabolism; interneuron; katp channel; mouse; neocortex; neuroscience; pyramidal cell; rat
Mesh:
Substances:
Year: 2021 PMID: 34766906 PMCID: PMC8651295 DOI: 10.7554/eLife.71424
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140
Figure 1.Detection of Kcnj11 and Abcc8 KATP channel subunits in cortical neuron subtypes.
(A) Ward’s clustering of 277 cortical neurons (left panel). The x-axis represents the average within-cluster linkage distance, and the y-axis the individuals. (B) Gene detection profile across the different cell clusters. For each cell, colored and white rectangles indicate presence and absence of genes, respectively. (C) Representative voltage responses induced by injection of current pulses (bottom traces) corresponding to −100, −50, and 0 pA, rheobase and intensity inducing a saturating firing frequency (shaded traces) of a regular spiking neuron (black), an intrinsically bursting neuron (gray), a bursting vasoactive intestinal polypeptide (Vip) interneuron (light blue), an adapting Vip interneuron (blue), an adapting Sst interneuron (green), an adapting Npy interneuron (orange), and a Fast Spiking-Parvalbumin interneuron (FS-Pvalb, red). The colored arrows indicate the expression profiles of neurons whose firing pattern is illustrated in (C). (D) Detection of the subunits of the KATP channels in the different clusters. Shaded rectangles represent potential Kcnj11 false positives in which genomic DNA was detected in the harvested material. (E) Single-cell RT-PCR (scRT-PCR) analysis of the regular spiking (RS) neuron depicted in (A–D). (F) Histograms summarizing the detection rate of KATP channel subunits in identified neuronal types. n.s., not statistically significant.
(A) RT-PCR products generated from 500 pg of total cortical RNAs. M: 100 bp ladder molecular weight marker. (B) Abcc9 splice variants-specific RT-PCR analysis of 1 ng total RNAs from rat heart, neocortex, and forebrain.
Yellow rectangles denote bands of the expected size.
Figure 1—figure supplement 1.Molecular expression of KATP channels.
(A) RT-PCR products generated from 500 pg of total cortical RNAs. M: 100 bp ladder molecular weight marker. (B) Abcc9 splice variants-specific RT-PCR analysis of 1 ng total RNAs from rat heart, neocortex, and forebrain.
Yellow rectangles denote bands of the expected size.
Figure 2.Pharmacological and biophysical characterization of KATP channels in cortical neurons.
(A) Representative voltage responses of a Fast Spiking-Parvalbumin (FS-Pvalb) interneuron induced by injection of current pulses (bottom traces). (B) Protocol of voltage pulses from −70 to −60 mV (left trace). Responses of whole-cell currents in the FS-Pvalb interneurons shown in (A) in control condition (black) and in presence of pinacidil (blue), piazoxide (green) and tolbutamide (red) at the time indicated by a–d in (C). (C) Stationary currents recorded at −60 mV (filled circles) and membrane resistance (open circles) changes induced by KATP channel modulators. The colored bars and shaded zones indicate the duration of application of KATP channel modulators. Upper and lower insets: changes in whole-cell currents and relative changes in membrane resistance induced by KATP channel modulators, respectively. (D) Whole-cell current–voltage relationships measured under diazoxide (green trace) and tolbutamide (red trace). KATP I/V curve (black trace) obtained by subtracting the curve under diazoxide by the curve under tolbutamide. The arrow indicates the reversal potential of KATP currents. Histograms summarizing the KATP current reversal potential (E, F) and relative KATP conductance (G,H) in identified neuronal subtypes (E, G) or between glutamatergic and GABAergic neurons (F, G). Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant. *, ** and *** indicate statistically significant with p< 0.05, 0.01 and 0.001 respectively.
(A) Representative stationary currents at −60 mV (filled circles) and membrane resistance (open circles) changes induced by diazoxide and tolbutamide under control condition and in presence of the superoxide dismutase and catalase mimetic, MnTMPyP. The colored bars and shaded zones indicate the duration of application. Histograms summarizing the relative KATP currents (B) and relative whole-cell KATP conductance (C) evoked by two consecutive diazoxide and tolbutamide applications in control condition (Ctrl.) and after the presence of MnTMPyP. Data are normalized by the data measured during first application, expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant.
Histograms summarizing the whole-cell KATP conductance (A, B) and KATP current density (C, D) and KATP current reversal potential in identified neuronal subtypes (A,C) or between glutamatergic and GABAergic neurons (B,D). Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant.
Figure 2—figure supplement 1.Diazoxide-induced current is independent of reactive oxygen species (ROS) production.
(A) Representative stationary currents at −60 mV (filled circles) and membrane resistance (open circles) changes induced by diazoxide and tolbutamide under control condition and in presence of the superoxide dismutase and catalase mimetic, MnTMPyP. The colored bars and shaded zones indicate the duration of application. Histograms summarizing the relative KATP currents (B) and relative whole-cell KATP conductance (C) evoked by two consecutive diazoxide and tolbutamide applications in control condition (Ctrl.) and after the presence of MnTMPyP. Data are normalized by the data measured during first application, expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant.
Figure 2—figure supplement 2.Characterization of KATP channels in different cortical neurons.
Histograms summarizing the whole-cell KATP conductance (A, B) and KATP current density (C, D) and KATP current reversal potential in identified neuronal subtypes (A,C) or between glutamatergic and GABAergic neurons (B,D). Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant.
Figure 3.KCNJ11 is the pore-forming subunit of KATP channels in cortical neurons.
(A) Representative voltage responses of a mouse layer II/III regular spiking (RS) pyramidal cell induced by injection of current pulses (bottom traces). (B) Histograms summarizing the detection rate of Slc17a7, Gad2 and 1, the Atp1a1-3 subunits of the Na/K ATPase and the Kcnj11 and Abcc8 KATP channel subunits in layer II/III regular spiking (RS) pyramidal cells from Kcnj11+/+ mice. (C, D) Whole-cell stationary currents recorded at 50 mV during dialysis with ATP-free pipette solution in cortical neurons of Kcnj11+/+ (C) and Kcnj11−/− (D) mice. Inset: voltage clamp protocol. (E, F) Current–voltage relationships obtained during ATP washout at the time indicated by green and orange circles in (C, D) in cortical neurons of Kcnj11+/+ (E) and Kcnj11−/− (F) mice. (G) Histograms summarizing the whole-cell ATP washout currents in Kcnj11+/+ (black) and Kcnj11−/− (white) cortical neurons. Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. Open symbols in Kcnj11+/+ and Kcnj11−/− bar plots indicate the cells illustrated in (C, D) and (E, F), respectively. (H) Diagram depicting the principle of the ATP washout experiment. *** indicates statistically significant with p< 0.001.
Figure 4.Modulation of cortical neuronal excitability and activity by KATP channels.
Representative example of a regular spiking (RS) neurons showing the changes in membrane potential (A), resistance (B, open circles) and spiking activity (C) induced by application of tolbutamide (red) and diazoxide (green). The colored bars and shaded zones indicate the application duration of KATP channel modulators. Relative changes in membrane potential (D), resistance (E), and firing rate (F) induced by tolbutamide and diazoxide in cortical neurons. Histograms summarizing the modulation of membrane potential (G, H(5,32) = 0.15856, p = 0.999, and H, U(8,24) = 96, p = 1.0000) and resistance (I, H(5,32) = 2.7566, p = 0.737, and J, U(8,24) = 73, p = 0.3345) by KATP channels in neuronal subtypes (G, I) and groups (H, J). Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant. * and *** indicate statistically ignificant with p<0.05 and 0.001.
Histograms summarizing the proportion of responsive neurons (A, Κ2(5) = 7.3125, p = 0.1984, and B, p = 1.0000) and modulation firing rate (C, H(5,32) = 5.0202, p = 0.413, and D, U(8,24) = 87, p = 0.7169) by KATP channels in neuronal subtypes (A, C) and groups (B, D). The numbers in brackets indicate the number of responsive cells and analyzed cells, respectively. Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant.
Figure 4—figure supplement 1.Modulation of neuronal activity in different cortical neurons by KATP channels.
Histograms summarizing the proportion of responsive neurons (A, Κ2(5) = 7.3125, p = 0.1984, and B, p = 1.0000) and modulation firing rate (C, H(5,32) = 5.0202, p = 0.413, and D, U(8,24) = 87, p = 0.7169) by KATP channels in neuronal subtypes (A, C) and groups (B, D). The numbers in brackets indicate the number of responsive cells and analyzed cells, respectively. Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant.
Figure 5.Lactate enhances cortical neuronal activity via KATP channel modulation.
(A) Representative perforated patch recording of an adapting vasoactive intestinal polypeptide (VIP) neuron showing the modulation of firing frequency induced by changes in the extracellular concentrations of metabolites. The colored bars and shaded zones indicate the concentration in glucose (gray) and lactate (orange). Voltage responses recorded at the time indicated by arrows. The red dashed lines indicate −40 mV. (B) Histograms summarizing the mean firing frequency during changes in extracellular concentration of glucose (black and gray) and lactate (orange). Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. n.s., not statistically significant. *, ** and *** indicate statistically significant with p< 0.05, 0.01 and 0.001, respectively. (C) Dose-dependent enhancement of firing frequency by lactate. Data are normalized by the mean firing frequency in absence of lactate and are expressed as mean ± SEM. Numbers in brackets indicate the number of recorded neurons at different lactate concentrations. (D) Histograms summarizing the normalized frequency under 15 mM lactate (orange) and its modulation by addition of diazoxide (green) or tolbutamide (red). Data are expressed as mean ± SEM, and the individual data points are depicted. n.s., not statistically significant. (E) Histograms summarizing the enhancement of normalized frequency by 15 mM lactate in Kcnj11+/+ (orange) and Kcnj11−/− (pale orange) mouse cortical neurons. The dash line indicates the normalized mean firing frequency in absence of lactate. Data are expressed as mean ± SEM, and the individual data points are depicted. (F) Diagram depicting the enhancement of neuronal activity by lactate via modulation of KATP channels.
Figure 6.Lactate enhancement of cortical neuronal activity involves lactate uptake and metabolism.
(A) Histograms summarizing the detection rate of the monocarboxylate transporters Slc16a1, 7, and 3 and Ldha and b lactate dehydrogenase subunits in glutamatergic neurons (black) and GABAergic interneurons (white). The numbers in brackets indicate the number of analyzed cells. (B) Histograms summarizing the enhancement of normalized frequency by 15 mM lactate (orange) and its suppression by the monocarboxylate transporters (MCTs) inhibitor α-cyano-4-hydroxycinnamic acid (4-CIN; purple). Data are expressed as mean ± standard error of the mean (SEM), and the individual data points are depicted. (C) Histograms summarizing the enhancement of normalized frequency by 15 mM lactate (orange) and pyruvate (magenta). Data are expressed as mean ± SEM, and the individual data points are depicted n.s., not statistically significant. (D) Widefield NADH (reduced form of nicotinamide adenine dinucleotide) autofluorescence (upper panel, scale bar: 20 µm) and corresponding field of view observed under IR-DGC (lower panel). The somatic regions of interest are delineated. (E) Mean relative changes in NADH autofluorescence in control condition (gray) and in response to 15 mM lactate (orange) or pyruvate (magenta). The colored bars indicate the duration of applications. Data are expressed as mean ± SEM. Inset: diagram depicting the NADH changes induced by lactate and pyruvate uptake by MCT and their interconversion by lactate dehydrogenase (LDH). (F) Histograms summarizing the mean relative changes in NADH autofluorescence measured during the last 5 min of 15 mM lactate (orange) or pyruvate (magenta) application and corresponding time in control condition (gray). Data are expressed as mean ± SEM, and the individual data points are depicted. (G) Widefield YFP fluorescence of the ATP biosensor AT1.03YEMK (upper left panel, scale bar: 30 µm) and pseudocolor images showing the intracellular ATP (YFP/CFP ratio value coded by pixel hue, see scale bar in upper right panel) and the fluorescence intensity (coded by pixel intensity) at different times under 10 mM extracellular glucose (upper right panel) and after addition of iodoacetic acid (IAA; lower left panel) and potassium cyanide (KCN; lower right panel). (H) Mean relative changes in intracellular ATP (relative YFP/CFP ratio) measured under 10 mM extracellular glucose (gray) and after addition of IAA (yellow) and KCN (blue). Data are expressed as mean ± SEM. The colored bars indicate the time and duration of metabolic inhibitor application. Inset: Histograms summarizing the mean relative changes in intracellular ATP (relative YFP/CFP ratio) ratio under 10 mM extracellular glucose (gray) and after addition of IAA (yellow) and KCN (blue). Data are expressed as mean ± SEM, and the individual data points are depicted. *, ** and *** indicate statistically significant with p< 0.05, 0.05 and 0.001, respectively.
Histograms summarizing the detection rate of the monocarboxylate transporterMCTs Slc16a1, 7, and 3 and Ldha and b LDHlactate dehydrogenase subunits in different neuronal subtypes. The numbers in brackets indicate the number of analyzed cells.
(A) Mean relative changes in NADH autofluorescence in control condition (gray) and in response to 1 mM potassium cyanide (KCN; blue). The colored bar indicates the duration of KCN applications. Data are expressed as mean ± SEM. (B) Histograms summarizing the mean relative changes in NADH autofluorescence measured during the last 5 min of 1 mM KCN application (blue) and corresponding time in control condition (gray). Data are expressed as mean ± SEM, and the individual data points are depicted. *** indicates statistically significant with p < 0.001.
Figure 6—figure supplement 1.Detection rate of monocarboxylate transporters and lactate dehydrogenase subunits in different cortical neuronal types.
Histograms summarizing the detection rate of the monocarboxylate transporterMCTs Slc16a1, 7, and 3 and Ldha and b LDHlactate dehydrogenase subunits in different neuronal subtypes. The numbers in brackets indicate the number of analyzed cells.
Figure 6—figure supplement 2.Neuronal NADH autofluorescence increase by blockade of oxidative phosphorylation.
(A) Mean relative changes in NADH autofluorescence in control condition (gray) and in response to 1 mM potassium cyanide (KCN; blue). The colored bar indicates the duration of KCN applications. Data are expressed as mean ± SEM. (B) Histograms summarizing the mean relative changes in NADH autofluorescence measured during the last 5 min of 1 mM KCN application (blue) and corresponding time in control condition (gray). Data are expressed as mean ± SEM, and the individual data points are depicted. *** indicates statistically significant with p < 0.001.
Figure 7.Diagram summarizing the mechanism of lactate sensing in the cortical network.
Glutamate (Glu) released during synaptic transmission stimulates (1) blood glucose (Glc) uptake in astrocytes, (2) aerobic glycolysis, (3) lactate release, and (4) diffusion through the astrocytic network. Lactate is then (5) taken up by neurons via monobarboxylate transporters (MCT) and (6) oxidized into pyruvate by lactate dehydrogenase (LDH). The ATP produced by pyruvate oxidative metabolism (7) closes KATP channels and increases the spiking activity of both pyramidal cells (black) and inhibitory interneurons (green). The color gradient of the circles represents the extent of glutamate (black) and lactate (orange) diffusion, respectively. Dashed arrows indicate multisteps reactions.
| Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Strain, strain background ( | Wistar | Janvier Labs | jHan:WI | |
| Strain, strain background ( | Wild type, | Janvier Labs | C57BL/6RJ | |
| Strain, strain background ( | B6.129P2- | PMID: | RRID: | |
| Cell line ( | BHK-21 clone 13 (baby hamster kidneys fibroblasts) | ATCC | CCL-10, RRID: | |
| Recombinant DNA reagent | pcDNA-ATeam1.03YEMK (plasmid) | PMID: | ||
| Recombinant DNA reagent | pSinRep5 (plasmid) | Invitrogen | K750-01 | |
| Recombinant DNA reagent | pDH(26 S) (helper plasmid) | Invitrogen | K750-01 | |
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat/mouse | PMID: | PCR primers |
|
| Sequence-based reagent | rat/mouse | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers | TGTCTGTGCGTGGTGATGGC |
| Sequence-based reagent | rat | PMID: | PCR primers | GCATAGCAACATTAGGTCTGGGAG |
| Sequence-based reagent | rat | PMID: | PCR primers | ATACATCCAGCAGGTCCGCAA |
| Sequence-based reagent | rat | PMID: | PCR primers | GGTCGTGTGCGTGGTTGTTT |
| Sequence-based reagent | rat | This paper | PCR primers | CTGGCTCACAAGAACATCCG |
| Sequence-based reagent | rat | This paper | PCR primers | AGCGTCTCTGCCCTTCTGTG |
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | PMID: | PCR primers |
|
| Sequence-based reagent | rat | PMID | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat SUR2A/B sense | This paper | PCR primers |
|
| Sequence-based reagent | rat SUR2A/B antisense | This paper | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | mouse | PMID: | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Sequence-based reagent | rat | This paper | PCR primers |
|
| Commercial assay or kit | MEGAscript SP6 Transcription Kit | Ambion | AM1330 | |
| Chemical compound, drug | Pinacidil monohydrate | Sigma-Aldrich | P154 | |
| Chemical compound, drug | Diazoxide | Sigma-Aldrich | D9035 | |
| Chemical compound, drug | Tolbutamide | Sigma-Aldrich | T0891 | |
| Chemical compound, drug | Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin | Millipore | 475,872 | |
| Chemical compound, drug | Gramicidin from Bacillus aneurinolyticus (Bacillus brevis) | Sigma-Aldrich | G5002 | |
| Chemical compound, drug | Sodium | Sigma-Aldrich | L7022 |
|
| Chemical compound, drug | α-Cyano-4-hydroxycinnamic Acid | Sigma-Aldrich | C2020 | |
| Chemical compound, drug | Sodium pyruvate | Sigma-Aldrich | P2256 | |
| Chemical compound, drug | Sodium iodoacetate | Sigma-Aldrich | I2512 | |
| Chemical compound, drug | Potassium cyanide | Sigma-Aldrich | 60,178 | |
| Chemical compound, drug | Dithiothreitol | VWR | 443,852 A | |
| Chemical compound, drug | Primer ‘random’ |
| ||
| Chemical compound, drug | dNTPs | GE Healthcare Life Sciences | 28-4065-52 | |
| Chemical compound, drug | Mineral Oil | Sigma-Aldrich | M5904 | |
| Chemical compound, drug | RNasin Ribonuclease Inhibitors | Promega | N2511 | |
| Chemical compound, drug | SuperScript II Reverse Transcriptase | Invitrogen |
| |
| Chemical compound, drug | Taq DNA Polymerase | Qiagen | 201,205 | |
| Chemical compound, drug | Penicillin-Streptomycin | Sigma-Aldrich | P4333-100ML | |
| Software, algorithm | Pclamp v 10.2 | Molecular Devices | RRID: | |
| Software, algorithm | Matlab v 2018b | MathWorks | RRID: | |
| Software, algorithm | Statistica v 6.1 | Statsoft | RRID: | |
| Software, algorithm | GraphPad Prism v 7 | GraphPad | RRID: | |
| Software, algorithm | ImagingWorkbench v 6.0.25 | INDEC Systems | ||
| Software, algorithm | FIJI | PMID: | RRID: | MID:29985318 |
| Software, algorithm | Image-Pro Analyzer v 7 | MediaCybernetics | ||
| Other | Vibratome | Leica | VT1000S RRID: | |
| Other | Upright microscope | Olympus | BX51WI | |
| Other | Dual port module | Olympus | WI-DPMC | |
| Other | ×60 Objective | Olympus | LUMPlan Fl /IR 60 x/0.90 W | |
| Other | ×40 Objetive | Olympus | LUMPlan Fl /IR 40 x/0.80 W | |
| Other | CCD camera | Roper Scientific | CoolSnap HQ2 | |
| Other | Axopatch 200B | Molecular Devices | RRID: | |
| Other | Digidata 1440A | Molecular Devices | RRID: | |
| Other | S900 stimulator | Dagan Corporation | ||
| Other | pE-2 | CoolLED | ||
| Other | Dichroic mirror | Semrock | FF395/495/610-Di01-25 × 36 | |
| Other | Emission filter | Semrock | FF01-425/527/685-25 | |
| Other | 780 nm Collimated LED | Thorlabs | M780L3-C1 | |
| Other | Dodt Gradient Contrast | Luigs and Neumann | 200-100 200 0155 | |
| Other | Beam splitter | Semrock | 725 DCSPXR | |
| Other | Analogic CCD camera | Sony | XC ST-70 CE | |
| Other | Millicell | Millipore | PICM0RG50 | |
| Other | Excitation filter | Semrock | FF02-438/24-25 | |
| Other | Dichroic mirror | Semrock | FF458-Di02-25 × 36 | |
| Other | Emission filter | Semrock | FF01-483/32-25 | |
| Other | Emission filter | Semrock | FF01-542/27-25 | |
| Other | Filter wheel | Sutter Instruments | Lambda 10B |